Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
about
Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissueThe woodchuck model of hepatitis B virus infection.Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer.The relation of infection with the hepatitis B agent to primary hepatic carcinoma.Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver diseaseSerological relationship of woodchuck hepatitis virus to human hepatitis B virus.Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinomaIncidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma.Histology and ultrastructural aspects of virus-induced primary liver cancer and transplantable hepatomas of viral origin in chickens.Geographic correlation between mortality from primary hepatic carcinoma and prevalence of hepatitis B surface antigen in Greece.Hepatitis-B: a review.Benign and malignant liver neoplasms: some new etiologic associations.Role of hepatitis B virus in primary liver cancer.Prevalence of hepatitis C virus antibodies in chronic liver disease and hepatocellular carcinoma patients in India.High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.The pattern of childhood malignancy in eastern Nigeria.Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.
P2860
Q33846758-24C2DF39-9106-4AAD-B627-6F8A17F4DCCDQ34282796-F2119D16-8AE3-4916-B052-5E7534245FBCQ36068374-F757C854-D679-47BA-AF5F-5D3DBE716CA8Q36077647-46A400DA-9D0A-451D-AC8F-9193C042BCD0Q36292751-48AC32D7-F2D3-4736-94E4-88C5A46B8B54Q36504039-056131FB-BF66-4FBB-8BAB-86B5593CFEC1Q36617249-7D7BB94B-4C0E-43D5-BEDD-C115B1E2F0D4Q37359400-473A2E72-52E3-4560-9BAE-C29397258A02Q37993890-ECA509E6-31C1-40DF-AE52-AEEA1E30CE4BQ39219059-13681A2D-64DE-4CB0-ABD1-3B7FA9792316Q39394508-F8332F3E-0227-4ADA-AE4F-BB2C10208BBAQ40131247-1A1E142E-9167-4A5E-A862-F7C352A4B8EEQ40246609-ECE65585-5E35-49B3-AFD8-EB53B486B925Q42981825-115DFAFA-6DC2-4033-9651-817B5810E4F2Q43039375-916E4C10-8852-4AD2-8212-AAD6DC472B59Q46414478-FD7837AC-8211-4518-847A-78BE066A4757Q53385661-47FA1C0E-2F6E-41C2-ABC2-9E31EA337ABD
P2860
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
@en
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
@nl
type
label
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
@en
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
@nl
prefLabel
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
@en
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
@nl
P2093
P1433
P1476
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.
@en
P2093
A O'Connell
B S Blumberg
W T London
P356
10.1016/S0140-6736(75)92951-7
P407
P577
1975-07-01T00:00:00Z